events
Mark your calendar for November 19-21 and meet us at Fi Europe 2024, Messe Frankfurt, Germany. We look forward to connecting with you at this exciting event!
Learn More >>
Products

Enzymes for Research, Diagnostic and Industrial Use

Products
Online Inquiry

Our Products Cannot Be Used As Medicines Directly For Personal Use.

24 hour
Promise

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.

Native β-hemolytic Streptococcus Streptokinase

Cat No.
NATE-0670
Description
Streptokinase (SK) is an enzyme secreted by several species of streptococci that can bind and activate human plasminogen. SK is used as an effective and inexpensive thrombolysis medication in some cases of myocardial infarction (heart attack) and pulmonary embolism. Streptokinase belongs to a group of medications known as fibrinolytics, and complexes of streptokinase with human plasminogen can hydrolytically activate other unbound plasminogen by activating through bond cleavage to produce plasmin. There are three domains to Streptokinase, denoted α (residues 1–150), β (residues 151–287), and γ (residues 288–414). Each domain binds plasminogen, although none can activate plasminogen independently.
Abbr
SK, Native (β-hemolytic Streptococcus)
Alias
SK
Source
β-hemolytic Streptococcus (Lancefield Group C)
Species
β-hemolytic Streptococcus
Applications
Streptokinase is commonly used as a thrombolytic agent in the therapy of ischemic stroke. This therapy carries the important risk of intracerebral hemorrhage. Streptokinase is also used in the treatment of complicated parapneumonic effusions and empyema where adverse reactions, allergic type, are rare. Streptokinase is commonly used as a thrombolytic agent in the therapy of ischemic stroke. This therapy carries the important risk of intracerebral hemorrhage. Streptokinase is also used in the treatment of complicated parapneumonic effusions and empyema where adverse reactions, allergic type, are rare. Streptokinase has been used in a study to compare primary coronary intervention and thrombolytic therapy in my ocardial infarction patients.
Product Overview
Streptokinase from β-hemolytic Strept oc occus, or Streptokinase from Strept oc occus hemolyticus, is effective in thrombolytic therapy.
Form
Lyophilized powder containing ~50% total protein by biuret and sodium glutamate. Total protein composed of enzyme protein and human serum albumin.
Enzyme Commission Number
EC 3.4.99.0
Activity
> 3,500 units/mg solid
CAS No.
9002-01-1
Unit Definition
One unit will liquify a standard clot of fibrinogen, plasminogen, and thrombin at pH 7.5 at 37°C in 10 min.
Storage
−20°C
Synonyms
Streptokinase; SK; EC 3.4.99.0; 9002-01-1

"SK" Total Products Page

Catalog Product Name EC No. CAS No. Source Price
PHAM-261 Native Streptococcus hemolyticus Streptokinase EC 3.4.99.0 9002-01-1 Streptococcus hemolyticus Inquiry
NATE-1630 Streptokinase from Streptococcus sp., Recombinant E.Coli Inquiry

Our Products Cannot Be Used As Medicines Directly For Personal Use.

0
Click unfold / close
Inquiry Basket
Delete selected Quote Check Out
Decide to move out of the shopping cart?
Sure No, Back

Please choose product!

< Go Back
You have already added to buy this product